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Abstract: Medication errors have a significant impact on patient outcomes, increase healthcare costs, 
and are a common cause of preventable morbidity. This single-site, observational, diagnostic 
accuracy study aimed to quantify medication discrepancies in transition of care from primary care 
to the emergency department (ED) over a 12-month period. Medication lists in General Practitioner 
(GP) referrals to a regional ED were examined against a Best Possible Medication History (BPMH) 
performed by a hospital pharmacist. One hundred and forty-three patients (25%) with computer-
generated GP referrals to ED who were subsequently admitted to hospital had a BPMH taken; 135 
(94%) of these had at least one medication discrepancy identified with a discrepancy rate of 67.18 
discrepancies per 100 medications. Improving medication reconciliation in the community may 
reduce the burden associated with preventable medication errors. Whether this is achieved by more 
frequent GP-led medication review or community-based pharmacist medication review may 
depend on the community and available resources. 
Keywords: medication; general practice; discrepancy; pharmacist; risk; referral; best practice 
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1. Introduction 
Medication errors have health and economic consequences for patients and health services. It is 
estimated that 2%–3% of all hospital Australian admissions are medication-related [1], with 66%–75% 
of patients having a medication error at time of admission [2,3] to an Australian hospital, 30% of 
which have potential to cause harm [4,5]. A recent review conducted by the United Kingdom (UK) 
National Health Service (NHS) found errors occurred at all stages of medication use, from prescribing 
and dispensing, through administration and monitoring, and they occurred in primary care (38.3%), 
care homes (41.7%), and secondary care (20%) [6]. Errors in primary care may contribute greatly to 
the burden on health systems due to the size of the sector, with the impact estimated to cost the NHS 
£98.5 million per year, consuming 181,626 bed-days, causing 712 deaths, and contributing to 1708 
deaths during hospitalisation [6]. The authors suggest UK rates are similar to those in comparable 
settings. There were, however, few quality studies of error rates during transition of care and most 
studies pertained to medication errors for patients discharged from hospital care. 
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Best practice medication management includes reconciling medicines on admission to a health 
service. A Best Possible Medication History (BPMH) involves a structured patient interview and 
confirmation with at least one other source and is often undertaken by the hospital pharmacist for 
admitted patients. High-risk medications include the anti-infectives, potassium and other 
electrolytes, insulin, narcotics and other sedatives, chemotherapeutic agents, and heparin and other 
anticoagulant (APINCH) medicines ([7]. Using the BPMH to compare with the medications listed in 
General Practitioner (GP) referrals, a multisite study conducted in Australian hospitals in 2008–2009 
found 87% of GP referrals had one or more discrepancies in the patients’ regular medications and 
62% had one or more regular medication discrepancies of moderate to high significance [8].  
Computerised medication systems or some computerised functionality is regarded as a key 
component of safer medication management. The purported benefits include auto population of 
medications into transfer of care documents such as referrals, minimising errors associated with 
‘cutting and pasting’, up-to-date and accurate lists, inclusion of new, suspended or changed 
medications supporting clinical handover communication, support of workflow that prompts 
medication review when patients are identified as a falls risk, and alerts for prescribers when 
prescribing look-alike, sound-alike and high-risk medications [7]. An accurate and complete current 
medication list is a key component of transfer of care documents such as referrals, discharge 
summaries, and the shared health summary (SHS) that is a crucial part of the Australian electronic 
MyHealth record system. A SHS is particularly recommended for patients with chronic medical 
conditions or following a 75+ health assessment and may be created and uploaded by a medical 
practitioner, usually the patients’ GP, a registered nurse, or an Aboriginal and Torres Strait Islander 
Health Practitioner [9]. With increased focus over the last decade on computerised systems including 
the MyHealth record to provide the right information, for the right patient, at the right time, we 
sought to quantify the medication discrepancies for patients referred to an emergency department 
(ED) who were subsequently admitted to hospital and had a Best Possible Medication History taken 
by a pharmacist. The overarching aim of this study was to identify where strategies to reduce 
persisting medication error might be best targeted. 
2. Materials and Methods  
This was a single-site, observational, diagnostic accuracy study undertaken for patients 
presenting to the ED of an Australian regional hospital between 1 June 2015 and 30 May 2016. Ethics 
approval was obtained from the Tasmanian Health and Medical Research Ethics Committee (Ref: 
H0015862).  
Patient records were identified retrospectively from the ED medical information system as being 
referred to the ED by a GP and subsequently admitted as an inpatient. For each patient record, a 
medication list provided by the GP was compared to the BPMH taken by the hospital pharmacist. 
The BPMH did not include any medications commenced in the ED as a discrepancy. Medication 
discrepancies were recorded as omissions, false inclusions, dose and frequency errors, route of 
administration error, class discrepancies and dosage or frequency omissions. 
Each discrepancy was given a risk rating by calculating the consequence and likelihood of 
occurrence using a Risk Assessment Matrix (Figure 1). The severity of the consequences was assessed 
by an emergency medicine clinician and rated as insignificant, minor, moderate or major. The 
likelihood of occurrence was assessed by an emergency medicine clinician and was rated as rare, 
unlikely, possible, likely, or almost certain. 
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Figure 1. Risk assessment matrix. 
3. Results 
A total of 563 patient records were scrutinised with 143 (25%) of these having both a GP referral 
and a best possible medication history. Of the 143 patient records, 74 were males and 69 females. A 
total of 135 (94%) of these histories contained at least one medication discrepancy, all of whom 
attended ED with computer-generated GP referrals. Inclusions were the most common discrepancy 
(40%) with omissions being the next most frequent (24.7%) (Table 1). The rate of medication error 
(number of medication discrepancies per 100 medications) was 67.18. 
Table 1. Frequency and type of medication discrepancy. 
Type of Discrepancy Frequency Percent 
Omission 152 24.7 
Inclusion 246 40.0 
Exclusion 106 17.2 
Dose error 54 8.7 
Frequency error 33 5.4 
Dosage and frequency omission 17 2.7 
Medication type 6 1.0 
Time 2 0.3 
Total 616 100 
3.1. Consequences 
Following clinical evaluation of the medication discrepancies, it was found that 94 (15.3%) of 
discrepancies were of moderate to major consequence (Table 2). The eight discrepancies of major 
consequence were seen in three patients. One patient had 13 discrepancies, of which three were of 
major consequence. One patient had five medications listed on their referral, none of which the 
patient was taking; the four medications not listed that the patient was found to be taking in the 
BPMH included an novel oral anticoagulant (NOAC) and a steroid. One patient had one medication 
listed in the GP referral the patient was not taking, whereas the BPMH found the patient was taking 
six unlisted medications, including Gliclazide and Metformin. The most common drugs associated 
with discrepancies of major consequence were insulin and another diabetic medication. 
Table 2. Consequences of discrepancies. 
Severity of Consequence  Frequency Percent 
Insignificant  274 44.4 
Minor 248 40.3 
Moderate 86 14.0 
Major 8 1.3 
Catastrophic 0 0 
Total 616 100 
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3.2. Likelihood 
The likelihood of consequences occurring was almost certain or likely in 28 (4.6%) instances 
(Table 3). 
Table 3. Likelihood of occurrence. 
Likelihood  Frequency Percent 
Almost certain  1 0.2 
Likely 27 4.4 
Possible 118 19.2 
Unlikely 265 43.0 
Rare 205 33.2 
Total 616 100 
3.3. Risk 
The consequence and likelihood data were utilised to determine a risk rating for the medication 
discrepancies. The majority (72.9%) of discrepancies were low risk (Table 4). However, the risk was 
high or extreme in 96 (15.6%) instances. 
Table 4. Risk rating. 
Type of Discrepancy Frequency Percent 
Extreme 8 2.1 
High 83 13.5 
Moderate 76 11.5 
Low 449 72.9 
Total 616 100 
The 13 extreme risk ratings were from discrepancies of major consequence which were likely (n 
= 7) or almost certain (n = 1) and applied to five patients. One patient presented with hypercalcaemia 
and the GP referral listed five diabetic medications the patient was not taking, and was missing the 
apixaban, cholecalciferol, magnesium and prednisone the patient was taking; one patient presented 
with abdominal pain, tachycardia, and atrial fibrillation and the referral contained one medication 
the patient was not taking, and was missing six medications the patient was taking; one patient 
presented with bilateral pulmonary infiltrate for whom the supplements fish oil, glucosamine and 
magnesium were missing from the GP referral; one patient presented with abdominal pain whose 
blood pressure medication was not recorded on the GP referral list nor were two medications for 
depression. In only one of these instances was the referring GP not the patient’s usual GP. 
The 78 high-risk ratings related to 35 patients, two of whom also had extreme ratings for some 
discrepancies. Of the remaining patients, one patient presenting with a diabetic foot ulcer had eight 
discrepancies rated as high risk, none of the 11 patient’s medications were contained in the referral; 
one patient presenting with shortness of breath and chest pain had three medications listed, only one 
of which the patient was taking, together with nine others missing in the referral, including a nitrate, 
nitrate spray and a vasodilator. In both instances, the referring GP was the patient’s usual GP.  
In 48.8% of the high-risk discrepancies the GP authoring the referral was listed as the patients 
usual GP, and no one GP was represented more than another. 
4. Discussion 
Medication errors have the potential for significant patient harm and cost to the health system. 
Computerised medication management is promoted to reduce the likelihood of error. In this study, 
the rate of medication discrepancies observed in General Practitioner (GP) patient referrals where at 
least one medication discrepancy occurred was 67% despite the use of computerised systems for 
medication management. One-quarter of these discrepancies were of a moderate to extreme risk.  
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The premise of having a nominated provider for the electronic health information summary 
(Australia), MyHealth record, is that it is critical to have shared health summaries (SHSs) that are 
clinically useful and effective for a range of different types of healthcare providers who may review 
them [9]. The World Health Organisation advocates the use of shared electronic medical records and 
an intersectoral approach to reorient health systems to person-centered care [5]. In this study, the 
important role of the hospital pharmacist in reconciling medications was highlighted. While it is 
unknown how or why so many medication discrepancies occurred, better medication reconciliation 
in the community is an opportunity for reducing burden associated with medication error. Whether 
this can be easily performed by the GP through more frequent medication review, or whether there 
is a role for the community pharmacist or general practice nurse, may depend on the community and 
available resources. 
This study was conducted at a single regional site; it is known that there are fewer GPs in rural 
towns per capita than in urban areas, and this area has an older population and a high rate of chronic 
health issues [10]. The rate of medication discrepancy was calculated from the number of referrals 
with at least one discrepancy present. As 6% of the sample did not contain any discrepancies, the 
overall rate of medication discrepancy is likely to be slightly lower. Nevertheless, that one-quarter of 
these were of moderate to extreme risk suggests there is considerable opportunity to improve patient 
health outcomes through better medication reconciliation in the community.  
5. Conclusions 
This paper presents clinically important data that can contribute to ongoing education, quality 
assurance and meaningful interaction between medical professionals. Improving medication 
reconciliation in the community may reduce the burden associated with preventable medication 
errors. Whether this is achieved by more frequent GP-led medication review or community-based 
pharmacist medication review may depend on the community and available resources. 
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